These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 2503041

  • 1. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor.
    Sato T, Hashizume T, Nakao K, Akiba S, Fujii T.
    Biochim Biophys Acta; 1989 Aug 18; 992(2):168-73. PubMed ID: 2503041
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
    Carmo LG, Hatmi M, Rotilio D, Vargaftig BB.
    Br J Pharmacol; 1985 Aug 18; 85(4):849-59. PubMed ID: 2994786
    [Abstract] [Full Text] [Related]

  • 4. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS, Johns A, Kleha J, Xie J, Wang Y, Bianchi J, Conley K.
    J Pharmacol Exp Ther; 1994 Mar 18; 268(3):1352-61. PubMed ID: 8138950
    [Abstract] [Full Text] [Related]

  • 5. Interference of the thromboxane antagonist SK&F 88046 with platelet activation and subsequent desensitization by arachidonic acid and the thromboxane mimetics U46619 and EP171.
    Vargaftig B, Joseph D, Hatmi M.
    Thromb Res; 1987 May 15; 46(4):509-17. PubMed ID: 3039684
    [Abstract] [Full Text] [Related]

  • 6. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I, Block HU, Mest HJ.
    Biomed Biochim Acta; 1984 May 15; 43(8-9):S389-92. PubMed ID: 6440555
    [Abstract] [Full Text] [Related]

  • 7. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H, Stegmeier K.
    Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
    Ahn CH, Romstedt KJ, Wallace LJ, Miller DD, Feller DR.
    Biochem Pharmacol; 1988 Aug 01; 37(15):3023-33. PubMed ID: 3134894
    [Abstract] [Full Text] [Related]

  • 9. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K, Halushka PV, Yan YT, Wong PY.
    J Pharmacol Exp Ther; 1994 Sep 01; 270(3):1192-6. PubMed ID: 7932171
    [Abstract] [Full Text] [Related]

  • 10. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
    Berrettini M, De Cunto M, Parise P, Grasselli S, Nenci GG.
    Eur J Clin Pharmacol; 1990 Sep 01; 39(5):495-500. PubMed ID: 1963845
    [Abstract] [Full Text] [Related]

  • 11. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
    de Chaffoy de Courcelles D, De Clerck F.
    Eur J Pharmacol; 1990 Mar 13; 188(2-3):161-9. PubMed ID: 2318257
    [Abstract] [Full Text] [Related]

  • 12. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
    Takahara K, Murray R, FitzGerald GA, Fitzgerald DJ.
    J Biol Chem; 1990 Apr 25; 265(12):6836-44. PubMed ID: 2139029
    [Abstract] [Full Text] [Related]

  • 13. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.
    Parent CA, Lagarde M, Venton DL, Le Breton GC.
    J Biol Chem; 1992 Apr 05; 267(10):6541-7. PubMed ID: 1532390
    [Abstract] [Full Text] [Related]

  • 14. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets.
    Swann PG, Venton DL, Le Breton GC.
    FEBS Lett; 1989 Jan 30; 243(2):244-6. PubMed ID: 2537230
    [Abstract] [Full Text] [Related]

  • 15. Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors.
    Bayon Y, Croset M, Daveloose D, Guerbette F, Chirouze V, Viret J, Kader JC, Lagarde M.
    J Lipid Res; 1995 Jan 30; 36(1):47-56. PubMed ID: 7706947
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influence of dietary fatty acids on membrane fluidity and activation of rat platelets.
    Heemskerk JW, Feijge MA, Kalafusz R, Hornstra G.
    Biochim Biophys Acta; 1989 Aug 08; 1004(2):252-60. PubMed ID: 2752022
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of platelet aggregation by monoclonal antibody reactive with beta 2-microglobulin chain of HLA complex.
    Curry RA, Messner RP, Johnson GJ.
    Science; 1984 May 04; 224(4648):509-11. PubMed ID: 6324346
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.